Deal Round-up 11/01/02

3i has invested $30m into Asian company DenseLight Semiconductors; Hyperwave secures E20m; US pharmaceutical gets European injection.

3i has invested $30m into Asian company DenseLight Semiconductors.

DenseLight Semiconductors, a company based in Singapore, has taken a $30m investment from 3i’s balance sheet and its $400m Asia Pacific Technology Fund, making it the company’s biggest shareholder.

DenseLight designs and makes proprietary high-end semiconductors for optical network components, which increase the speed and efficiency of broadband networks. The company has already used part of 3i’s investment for recruitment and to set up its production and research facilities at Changi North. The remaining funds will be used for research and operations.

Hyperwave secures E20m

Hyperwave, a German software start-up has taken E20m first round funding from a group of investors led by e-millennium fund. The start-up develops data management software for around 170 companies including DaimlerChrysler, BMW, Fujitsu Siemens Computers and the US Government.

E-millennium is a E210m fund backed by the likes of Deutsche Bank, Accenture and SAP that was launched in April 2000. Participants in the funding included Atlas Venture, Deutsche Venture Capital and 3i.

US pharmaceutical gets European injection

Deutsche Venture Capital has injected $2.2m into Protarga, a US clinical stage pharmaceutical company developing new drugs for the treatment of cancer, central nervous system disorders and infectious diseases. The total round came to $24m, Switzerland’s Equity4Life also invested.

Currently DVC has around E300m under management. The firm has offices in Berlin, Frankfurt, Munich and Menlo Park in the US. It is also a partner of Deutsche Bank.